Human medicines European public assessment report (EPAR): Leflunomide ratiopharm, leflunomide, Date of authorisation: 28/11/2010, Revision: 20, Status: Authorised

Agenda - Management Board meeting: 17-18 December 2025

Human medicines European public assessment report (EPAR): Mepact, mifamurtide, Date of authorisation: 06/03/2009, Revision: 22, Status: Authorised

Minutes of the PRAC meeting 27 - 30 October 2025

Human medicines European public assessment report (EPAR): Caelyx pegylated liposomal, doxorubicin, Date of authorisation: 20/06/1996, Revision: 39, Status: Authorised

Human medicines European public assessment report (EPAR): Azacitidine Kabi, azacitidine, Date of authorisation: 05/01/2024, Revision: 2, Status: Authorised

Fiasp PumpCart (insulin aspart)

Name Review Group form - questions and answers

NovoRapid PumpCart (insulin aspart)

Human medicines European public assessment report (EPAR): Breyanzi, lisocabtagene maraleucel, Date of authorisation: 04/04/2022, Revision: 11, Status: Authorised